Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure.

American heart journal

Volumn 145, Issue 1, 2003, Pages

  Tomiyama, Hirofumi ^a   Watanabe, Gohki ^a   Yoshida, Hideo ^a   Doba, Nobutaka ^a   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE;

ARTICLE; BLOOD; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; URINE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASCORBIC ACID; CROSS-OVER STUDIES; CYCLIC GMP; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; FUROSEMIDE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS;

MLCS; MLOWN;

EID: 18144454046     PISSN: None     EISSN: 10976744     Source Type: Journal    
DOI: 10.1067/mhj.2003.42     Document Type: Article

References (0)